Barbara S. Wiggins

4.3k total citations · 3 hit papers
40 papers, 1.8k citations indexed

About

Barbara S. Wiggins is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Barbara S. Wiggins has authored 40 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 11 papers in Internal Medicine and 10 papers in Surgery. Recurrent topics in Barbara S. Wiggins's work include Venous Thromboembolism Diagnosis and Management (11 papers), Antiplatelet Therapy and Cardiovascular Diseases (9 papers) and Atrial Fibrillation Management and Outcomes (8 papers). Barbara S. Wiggins is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (11 papers), Antiplatelet Therapy and Cardiovascular Diseases (9 papers) and Atrial Fibrillation Management and Outcomes (8 papers). Barbara S. Wiggins collaborates with scholars based in United States, Belgium and Canada. Barbara S. Wiggins's co-authors include Robert L. Page, Sarah A. Spinler, Pamela B. Morris, Carol W. Holtzman, Joseph J. Saseen, David P. Wacker, Wendy K. Berg, Paul P. Dobesh, Ty J. Gluckman and Deborah Siegal and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Critical Care Medicine.

In The Last Decade

Barbara S. Wiggins

36 papers receiving 1.7k citations

Hit Papers

2017 ACC Expert Consensus Decision Pathway on Management ... 2016 2026 2019 2022 2017 2016 2020 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara S. Wiggins United States 15 761 405 384 164 163 40 1.8k
Nancy M. Allen LaPointe United States 29 2.0k 2.6× 463 1.1× 176 0.5× 589 3.6× 102 0.6× 105 3.4k
Lars Frison Sweden 27 2.9k 3.8× 676 1.7× 1.8k 4.6× 34 0.2× 87 0.5× 53 4.2k
W W Yeo United Kingdom 25 960 1.3× 700 1.7× 103 0.3× 69 0.4× 39 0.2× 83 2.6k
Jeffrey Schein United States 24 705 0.9× 335 0.8× 285 0.7× 32 0.2× 51 0.3× 58 1.9k
Charles E. Leonard United States 26 516 0.7× 320 0.8× 86 0.2× 268 1.6× 130 0.8× 127 2.3k
Diana M Sobieraj United States 26 434 0.6× 298 0.7× 267 0.7× 153 0.9× 46 0.3× 93 2.3k
Marco Proietti Italy 39 3.8k 5.0× 368 0.9× 864 2.3× 252 1.5× 28 0.2× 220 5.0k
Vicente Bertomeu‐González Spain 27 1.9k 2.5× 565 1.4× 115 0.3× 184 1.1× 60 0.4× 186 3.0k
Stefano Fumagalli Italy 25 1.2k 1.5× 176 0.4× 54 0.1× 300 1.8× 123 0.8× 127 2.3k
Joseph J. Saseen United States 28 693 0.9× 842 2.1× 60 0.2× 822 5.0× 76 0.5× 152 3.1k

Countries citing papers authored by Barbara S. Wiggins

Since Specialization
Citations

This map shows the geographic impact of Barbara S. Wiggins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara S. Wiggins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara S. Wiggins more than expected).

Fields of papers citing papers by Barbara S. Wiggins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara S. Wiggins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara S. Wiggins. The network helps show where Barbara S. Wiggins may publish in the future.

Co-authorship network of co-authors of Barbara S. Wiggins

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara S. Wiggins. A scholar is included among the top collaborators of Barbara S. Wiggins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara S. Wiggins. Barbara S. Wiggins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dixon, Dave L., et al.. (2022). Select drug-drug interactions with colchicine and cardiovascular medications: A review. American Heart Journal. 252. 42–50. 6 indexed citations
2.
Wiggins, Barbara S.. (2021). Human Angiopoietin-like Protein 3/ANGPTL3 Antibodies: Adding to the Armamentarium in the Management of Dyslipidemia. Journal of Cardiovascular Pharmacology. 78(5). e631–e640.
3.
Wiggins, Barbara S., et al.. (2021). Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Weighing ≥ 120 Kilograms versus 60–120 Kilograms. American Journal of Cardiovascular Drugs. 21(5). 545–551. 7 indexed citations
4.
Wiggins, Barbara S., Dave L. Dixon, Ron Neyens, Robert L. Page, & Ty J. Gluckman. (2020). Select Drug-Drug Interactions With Direct Oral Anticoagulants. Journal of the American College of Cardiology. 75(11). 1341–1350. 94 indexed citations
5.
Tomaselli, Gordon F., Kenneth W. Mahaffey, Adam Cuker, et al.. (2020). 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants. Journal of the American College of Cardiology. 76(5). 594–622. 201 indexed citations breakdown →
6.
Hilleman, Daniel E., Barbara S. Wiggins, & Michael B. Bottorff. (2020). Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review. Advances in Therapy. 37(2). 656–670. 30 indexed citations
7.
Barua, Rajat S., Nancy A. Rigotti, Neal L. Benowitz, et al.. (2018). 2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment. Journal of the American College of Cardiology. 72(25). 3332–3365. 197 indexed citations
8.
Wiggins, Barbara S., et al.. (2018). Evolocumab: Considerations for the Management of Hyperlipidemia. Current Atherosclerosis Reports. 20(4). 17–17. 11 indexed citations
9.
Tomaselli, Gordon F., Kenneth W. Mahaffey, Adam Cuker, et al.. (2017). 2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants. Journal of the American College of Cardiology. 70(24). 3042–3067. 263 indexed citations breakdown →
10.
Wiggins, Barbara S., Joseph J. Saseen, & Pamela B. Morris. (2016). Gemfibrozil in Combination with Statins—Is It Really Contraindicated?. Current Atherosclerosis Reports. 18(4). 18–18. 11 indexed citations
11.
Jackevicius, Cynthia A., Robert L. Page, Sheryl L. Chow, et al.. (2008). High‐Impact Articles Related to the Management of Heart Failure: 2008 Update. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 29(1). 82–120. 7 indexed citations
12.
Dobesh, Paul P., Sara D. Brouse, William E. Dager, et al.. (2007). Key Articles and Guidelines in the Management of Acute Coronary Syndromes and in Percutaneous Coronary Intervention: 2007 Update. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(12). 1722–1758. 3 indexed citations
13.
Buck, Marcia L., et al.. (2007). Intraosseous Drug Administration in Children and Adults During Cardiopulmonary Resuscitation. Annals of Pharmacotherapy. 41(10). 1679–1686. 89 indexed citations
14.
Dager, William E., Cynthia A. Sanoski, Barbara S. Wiggins, & James E. Tisdale. (2006). Pharmacotherapy Considerations in Advanced Cardiac Life Support. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(12). 1703–1729. 12 indexed citations
15.
Levine, Glenn N., Peter B. Berger, David J. Cohen, et al.. (2006). Newer Pharmacotherapy in Patients Undergoing Percutaneous Coronary Interventions: A Guide for Pharmacists and Other Health Care Professionals. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(11). 1537–1556. 11 indexed citations
16.
Holtzman, Carol W., Barbara S. Wiggins, & Sarah A. Spinler. (2006). Role of P‐glycoprotein in Statin Drug Interactions. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(11). 1601–1607. 148 indexed citations
17.
Wiggins, Barbara S., Sarah A. Spinler, Ann K. Wittkowsky, & Kathleen A. Stringer. (2002). Bivalirudin: A Direct Thrombin Inhibitor for Percutaneous Transluminal Coronary Angioplasty. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 22(8). 1007–1018. 13 indexed citations
18.
Wiggins, Barbara S., Ann K. Wittkowsky, & Jean M. Nappi. (2001). Clinical Use of New Antithrombotic Therapies for Medical Management of Acute Coronary Syndromes. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(3). 320–337. 2 indexed citations
19.
Berg, Wendy K., et al.. (1995). A Demonstration of Generalization of Performance Across Settings, Materials, and Motor Responses for Students with Profound Mental Retardation. Behavior Modification. 19(1). 119–143. 11 indexed citations
20.
Wacker, David P., et al.. (1988). TRAINING STUDENTS WITH PROFOUND OR MULTIPLE HANDICAPS TO MAKE REQUESTS VIA MICROSWITCHES. Journal of Applied Behavior Analysis. 21(4). 331–343. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026